halalkhor F, poorrahim A, Siahkouhian M. Effect of saffron supplementation and endurance training on interleukin-6, interleukin-10 and L-cysteine concentrations in outpatients with coronavirus. J Arak Uni Med Sci 2023; 26 (5) :1-8
URL:
http://jams.arakmu.ac.ir/article-1-7646-en.html
1- Mohaghegh Ardabili University
2- Mohaghegh Ardabili University , amenehpoorrahim@yahoo.com
Abstract: (1106 Views)
Background and purpose: Anti-cytokine considerations in covid-19 patients can play a significant role in preventing death, therefore, physical activity by reducing risk factors, as well as saffron with anti-inflammatory and antioxidant properties, are considered as anti-cytokine solutions. Therefore, the purpose of this research is to investigate the effect of saffron supplementation and endurance training on the concentration of interleukin-6, interleukin-10 and cysteine in outpatients with coronavirus.
Materials and methods: The statistical population of this research is outpatients with coronavirus, 36 of whom were randomly selected. Cytokines and cysteine were measured using a special kit and ELISA method. The research hypotheses were checked using SPSS software at a significance level of P<0.05 using ANOVA test with repeated measurements with between-group factor.
Results: The results showed that endurance activity and saffron supplementation caused a significant decrease in IL-6 levels and the ratio of interleukin 6 to interleukin 10 (P≥0.05). Also, endurance activity along with saffron supplementation caused a significant increase in serum L-cysteine concentration (P=0.035). The results showed that there is no interaction effect between the measurement stages and the group, as well as intra-group and inter-group differences in interleukin-10 variables (P=0.511).
Conclusion: The levels of IL-6 and IL-10 decrease due to saffron supplementation and endurance training, and the amount of cysteine increases, which helps the recovery of covid-19 patients.
Type of Study:
Original Atricle |
Subject:
COVID-19 Received: 2024/02/23 | Accepted: 2024/04/15